50.00% 0.000100

Effector Therapeutics Inc (EFTR)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

Relative Volume:

Effector Therapeutics Inc Stock (EFTR) Company Profile

Effector Therapeutics Inc

Healthcare (1080)

Biotechnology (604)

최신 SEC 제출 서류

EFTR's Discussions on Twitter

Compare EFTR vs VRTX, REGN, ARGX, MRNA, RVMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
EFTR Effector Therapeutics Inc	0.0003	0	675.00K	-34.63M	-29.28M	-13.32
VRTX Vertex Pharmaceuticals Inc	548.05	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	834.04	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,039.78	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.13	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.46	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Effector Therapeutics Inc Stock (EFTR) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2022-01-25	다운그레이드	Stifel	Buy → Hold
2021-11-09	업그레이드	Stifel	Hold → Buy
2021-10-12	개시	Credit Suisse	Outperform
2021-10-04	개시	Mizuho	Buy
2021-09-21	개시	JMP Securities	Mkt Outperform
2021-09-20	개시	Stifel	Hold
2021-09-13	개시	Cantor Fitzgerald	Overweight

Effector Therapeutics Inc 주식(EFTR)의 최신 뉴스

Effector Therapeutics Inc (EFTR) 재무 분석

Effector Therapeutics Inc (EFTR)

Effector Therapeutics Inc Stock (EFTR) Company Profile

Compare EFTR vs VRTX, REGN, ARGX, MRNA, RVMD

Effector Therapeutics Inc Stock (EFTR) Upgrades & Downgrades

Effector Therapeutics Inc 주식(EFTR)의 최신 뉴스

Better Therapeutics, Inc. (BTTX) Stock Price, News, Quote & History - Yahoo Finance

Effector Therapeutics Inc (NASDAQ: EFTR) Share Price, EFTR Stock News, EFTR Share Price & Updates - Kalkine

Enterprise value to revenue forward of eFFECTOR Therapeutics Inc – MUN:LWK - TradingView

Competitive Analysis: Leading Companies and New Entrants in - openPR.com

Expanded Access And Rollover Design Help CytoDyn Reach High-Need Cancer Patients - Clinical Leader

Attovia Therapeutics Appoints John W. Smither to Board of Directors - WBOC TV

If You Invested $1,000 in Ampio Pharma (AMPE) - Stock Titan

If You Invested $1,000 in Effector Therapeutics Inc (EFTR) - Stock Titan

If You Invested $1,000 in Innoveren Scientific Inc (IVRN) - Stock Titan

Price to earnings forward of eFFECTOR Therapeutics, Inc. – OTC:EFTR - TradingView

Price to book forward of eFFECTOR Therapeutics Inc – GETTEX:LWK - TradingView

Price to sales forward of eFFECTOR Therapeutics, Inc. – OTC:EFTR - TradingView

Price to sales forward of eFFECTOR Therapeutics Inc – GETTEX:LWK - TradingView

Enterprise value to EBITDA forward of eFFECTOR Therapeutics, Inc. – OTC:EFTR - TradingView

Enterprise value to EBITDA forward of eFFECTOR Therapeutics Inc – GETTEX:LWK - TradingView

eFFECTOR Therapeutics Inc Actuals & Estimates (OTC:EFTR) - TradingView

eFFECTOR Therapeutics Inc Actuals & Estimates (LS:A3ELKJ) - TradingView

PD-1 and PD-L1 Inhibitors Market Business Intelligence and Forecast Report 2026 to 2035 - openPR.com

What Does the Future Hold for Immune Effector Cell Therapies? - CancerNetwork

Calumet, IncCommon Stock (NQ: CLMT - FinancialContent

In vivo reprogramming of cytotoxic effector CD8 T cells via fractalkine-conjugated mRNA-LNPs - Science | AAAS

Bioinorganic Site-Specific Conjugation of Multi-Arm Linkers to Create Pharmaceuticals With Targeting and Effector Functions - Wiley Online Library

Non-covid mRNA Vaccine and Therapeutics Market Supply Chain Analysis and Revenue Forecast 2026 to 2035 - openPR.com

Analysis of Key Market Segments Influencing the RNA Targeting Small Molecules Therapeutics Market - openPR.com

DNA-guided CRISPR–Cas12a effectors for programmable RNA recognition and cleavage - Nature

Insider ownership and executive pay at CERo Therapeutics (NASDAQ: CERO) - Stock Titan

Stock List: Research Stocks from Around the World - GuruFocus

eFFECTOR Therapeutics Inc (EFTRW) - Minichart

IOBTQ Stock Price and Chart — OTC:IOBTQ - TradingView

Entia Biosciences, Inc. (ERGO) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore

Celularity Inc. (CELU) stock price, news, quote and history - uk.finance.yahoo.com

Novartis to acquire Excellergy for up to $2 billion - National Today

Excellergy to be acquired by Novartis for up to USD 2 - GlobeNewswire

Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors - Yahoo Finance

Selective fluorination of Fc glycans enhances antibody-mediated effector functions - PNAS

EFTR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - bioinformant.com

EFTR Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

CapEx per share of eFFECTOR Therapeutics Inc – MUN:LWK - TradingView

MBX Biosciences (Nasdaq: MBX) adds Burlington lab, names interim CFO - Stock Titan

Reprogramming The Tumor Microenvironment Bringing A Metabolic Checkpoint Therapy Into The Clinic - Clinical Leader

Head-To-Head Comparison: eFFECTOR Therapeutics (NASDAQ:EFTR) & Bio-Path (NASDAQ:BPTH) - Defense World

ZIMCF Stock Price, News & Analysis - Stock Titan

Functional antibody signatures following therapeutic immunization in Simian and Human immunodeficiency virus infection - Nature

Medical Crossfire® From Frontline to Heavily Pretreated HR+/HER2- Metastatic Breast Cancer: Expert Perspectives on Optimizing the Expanding Treatment Armamentarium - OncLive

Indian American Premal Patel joins Elephas Biosciences as CMO - The American Bazaar

Working (Well) With Patient Advocates: The Sponsor POV - Clinical Leader

ELEPHAS BIOSCIENCES STRENGTHENS SCIENTIFIC AND CLINICAL LEADERSHIP AS COMPANY ADVANCES TOWARD COMMERCIAL AVAILABILITY OF ITS LIVE-TUMOR IMMUNOLOGY PLATFORM - PR Newswire

Reaching Patients Where They Are: Moving CGT Care into the Community - HMP Global Learning Network

FACT's New Standards for Immune Effector Cells in the Community Clinical Setting Help Bring Cell Therapies Closer to Patients - Yahoo Finance

cells from effector T cells for cell therapy of inflammatory diseases - Science | AAAS

Effector Therapeutics Inc (EFTR) 재무 분석

매출

순이익

현금흐름

주당 순 이익

EFTR과 유사한 종목